Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

(R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)morpholine derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases

US Patent 12391681 · Granted Aug 19, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →